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Summary  Experimental  and  clinical  studies  have  shown  that  right  ventricular  apical  pacing
may result  in  long-term  deleterious  effects  on  account  of  its  negative  impact  on  left  ventricu-
lar remodeling  through  desynchronization.  This  risk  appears  more  pronounced  in  patients  with
even moderate  left  ventricular  dysfunction  and  generally  occurs  after  at  least  1  year  of  pacing.
As right  ventricular  apical  pacing  may  be  associated  with  the  development  of  organic  mitral
insufﬁciency,  other  sites  that  allow  for  more  physiological  stimulation,  such  as  right  ventricular
outﬂow tract  septal  pacing,  have  been  developed,  with  good  feasibility  and  reproducibility.
However, the  prospective  randomized  studies  and  meta-analyses  to  date  have  only  demon-
strated a  modest  effect  on  ejection  fraction  in  the  medium  term,  without  any  signiﬁcant  effect
on quality  of  life  and  morbimortality.  However,  the  absence  of  a  favorable  effect  for  right  ven-
tricular outﬂow  tract  septal  pacing  compared  with  right  ventricular  apical  pacing  in  terms  of
clinical manifestations  and  patient  prognosis  appears  to  be  more  associated  with  the  designs
of these  studies,  which  were  not  homogeneous  with  regard  to  methodology  used,  judgment
criteria, follow-up  and,  especially,  statistical  power.  Two  randomized  prospective  multicentre
studies are  currently  ongoing  in  order  to  evaluate  the  favorable  effect  of  infundibular  septal
pacing, when  considering  the  indirect  negative  effects  of  right  ventricular  apical  pacing  as
reported  in  the  literature.
©  2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  Les  études  expérimentales  et  cliniques  ont  montré  que  la  stimulation  ventriculaire
droite apicale  peut  avoir  des  effets  délétères  sur  le  long  terme  du  fait  de  son  impact  négatif
sur le  remodelage  ventriculaire  par  le  biais  de  la  désynchronisation.  Ce  risque  semble  plus
marqué chez  les  patients  avec  dysfonction  ventriculaire  gauche  même  modérée  et  s’exprime
généralement  après  au  moins  un  an  de  stimulation.  Il  peut  être  associé  au  développement
d’une insufﬁsance  mitrale  organique.  Par  conséquent,  d’autres  sites  de  stimulation  plus  physi-
ologique  comme  la  stimulation  septale  infundibulaire  ont  été  développés  avec  une  excellente
faisabilité  et  reproductibilité.  Malheureusement,  les  études  prospectives  randomisées  et  les
méta-analyses  n’ont  jusqu’alors  démontré  qu’un  effet  modeste  à  moyen  terme  sur  la  fraction
d’éjection  sans  effet  signiﬁcatif  sur  la  qualité  de  vie  et  la  morbidité.  L’absence  d’effet  favorable
de la  stimulation  septale  infundibulaire  par  rapport  à  la  stimulation  ventriculaire  droite  apicale
sur les  manifestations  cliniques  et  le  pronostic  des  patients  semble  plus  liée  à  la  méthodolo-
gie des  études  qui  ne  sont  pas  homogènes  entre  elles  en  termes  de  méthodologie,  de  critère
de jugement,  de  suivi,  et  surtout  de  puissance.  Deux  études  prospectives  randomisées  multi-
centriques  sont  en  cours  qui  devraient  aboutir  très  certainement  sur  un  effet  favorable  de  la
stimulation  septale  infundibulaire  si  l’on  se  base  sur  tous  les  effets  indirects  négatifs  démontrés
dans la  littérature  avec  la  stimulation  ventriculaire  droite  apicale.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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rWhy is an alternative to right ventricular
apical  pacing needed?
Physiopathological consequences of right
ventricular apical pacing
The  concept  of  preventing  ventricular  desynchronization
while  avoiding  stimulation  of  the  RV  apex  dates  back  to
the  middle  of  the  1990s  [1].  Several  experimental  studies
reported  that  the  degree  of  ventricular  dyssynchrony  during
RV  pacing  was  dependent  on  several  physiological  proper-
ties  of  the  myocardium:  electrical  conduction  at  least  four
times  slower  in  the  myocardium  compared  with  that  in  the
Purkinje  system;  conduction  along  muscle  ﬁbres  twice  as
fast  compared  with  perpendicular  activation,  such  as  during
RVAP,  when  the  activation  front  becomes  ellipsoidal,  result-
ing  in  slowed  conduction,  particularly  in  the  intermediate
and  epicardial  layers  [2];  inability  of  the  electrical  impulses
in  the  myocardium  to  reactivate  the  Purkinje  system,  as
shown  experimentally  by  Myerburg  et  al.  [3];  a  different
conduction  between  the  endocardial  and  epicardial  lay-
ers  on  account  of  the  smaller  endocardial  circumference
[4].  All  these  tissue  properties  consequently  affect  the
movement  of  the  electrical  impulse  from  the  RV  to  the
LV.  Several  studies  have  shown  that  the  LV  is  generally
activated  at  least  50  to  70  ms  after  the  initial  RV  acti-
vation,  at  100  ms  on  average,  with  a  gradual  movement
from  the  septum  towards  the  posterior-inferior  wall,  which
is  the  last  area  of  the  LV  to  be  activated  [5].  It  is  thus
not  surprising  that  electrical  asynchrony  is  responsible  for
both  inter-  and  intradyssynchrony  in  LV  myocardial  contrac-
tion.  This  asynchrony  not  only  depends  on  the  beginning
of  the  contraction  but,  more  importantly,  on  the  contrac-
tion  mode,  load  conditions  and  ﬁbre  orientation  in  relation
to  the  underlying  myocardial  state.  If  the  septum  is  acti-
vated  ﬁrst  during  RVAP,  the  different  phases  of  contraction
will  likely  depend  on  interactions  with  other  tissue  areas,
which  are  in  either  the  contraction  or  the  relaxation  phase
v
o
a
[6]. When  analysing  contraction  asynchrony  using  ultrasound
maging,  ‘paradoxical’  septal  motion  is  found,  which  actu-
lly  results  from  various  forces  exerted  in  relation  to  the
ovement  between  the  RV  and  LV,  thus  producing  pres-
ure  differences  across  the  septum.  Several  studies  have
emonstrated  that  asynchrony  has  an  impact  on  both  sys-
olic  and  diastolic  functions  as  well  as  on  other  phases,
articularly  isovolumetric  relaxation  and  contraction  [7].
umerous  phenomena  secondary  to  inter-  and  intraLV  asyn-
hrony  develop  over  time,  such  as  perfusion  abnormalities,
xygen  demand,  histological  modiﬁcations,  localized  hyper-
rophic  areas,  dilatation  of  ventricular  cavities,  occurrence
f  mitral  insufﬁciency,  ﬁlling  problems  and  decreased  car-
iac  output  secondary  to  reduced  ﬁlling  and  ejection.
urthermore,  the  long-term  structural  consequences  are
urrently  known,  involving  decreased  EF  and  frequent  mitral
nsufﬁciency  [7,8].
echanical consequences of RVAP versus
eptal pacing
he  short-term  as  well  as  long-term  mechanical  conse-
uences  of  permanent  apical  pacing  were  evaluated  in  two
ecent  studies  [9,10].  Delgado  et  al.  demonstrated  a  detri-
ental  acute  effect  of  RVAP  on  global  LV  function  in  25
ealthy  patients  [9].  A  more  dyssynchronous  LV  contrac-
ion  was  observed  in  the  patient  group  together  with  an
mpairment  in  LV  longitudinal  shortening  and  twist,  using
wo-dimensional  speckle-tracking  strain  imaging  [9].  The
ong-term  effect  was  also  evaluated  in  58  patients  with
ormal  LVEF  who  were  prospectively  randomized  to  pac-
ng  either  from  the  right  ventricular  apex  or  the  RVOT
eptum.  After  29  ±  10  months,  there  was  a  signiﬁcant  dete-
ioration  in  LVEF,  LV  end-systolic  volume  and  left  atrial
olume,  favouring  the  RVOT  septal-paced  group  [10].  More-
ver,  the  RVAP  mode  was  associated  with  greater  inter-
nd  intraventricular  dyssynchrony  than  RVOT  septal  pacing
10].
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otential clinical consequences of RVAP
he  combination  of  acute  haemodynamic  effects  and  ven-
ricular  remodelling  explains  why  electrical  and  mechanical
synchrony  may  exhibit  adverse  clinical  consequences  in
he  long-term  [8—16].  Several  studies  showed  that  RV  pac-
ng  exerted  a  negative  impact  on  long-term  morbimortality
ates  compared  with  atrial  pacing,  for  example,  which  was
referable  in  certain  indications,  such  as  sinus-node  dys-
unction  [8—16].  Despite  the  fact  that  these  studies  did  not
ompare  septal  pacing  and  apical  pacing,  the  detrimental
ong-term  effects  of  ventricular  pacing  argue  for  seeking
lternative  more  physiological  pacing  sites.
In  the  main  randomized  studies  involving  patients  with
inus-node  dysfunction  but  normal  LV  function,  the  risk  of
eart  failure  and  AF  was  signiﬁcantly  higher  during  RVAP,
howing  a  deleterious  long-term  effect  compared  with  pref-
rential  atrial  pacing,  the  latter  being  more  physiological
17—23].  Several  studies  demonstrated  a  negative  correla-
ion  between  increased  percentage  of  RVAP  and  long-term
ardiovascular  events  [19].  A  subanalysis  from  the  MOST
tudy  highlighted  the  strong  risk  of  AF  and  hospitalization
or  heart  failure  in  the  two  patient  groups  treated  using
he  DDD  (n  =  707)  and  VVI  (n  =  632)  pacing  modes  [15].  The
isk  occurred  at  a  cut-off  value  of  more  than  40%  for  RVAP
n  the  DDD  group  (HR  2.6;  P  <  0.05)  and  more  than  80%
n  the  VVI  group  [16].  In  the  DAVID  study,  patients  with
n  indication  for  implantable  automatic  deﬁbrillator  but
ot  for  cardiac  pacing  were  randomized  into  two  groups:
DD  (heart  rate  <  70  beats/minute)  and  VVI  (heart  rate  <  40
eats/minute)  [16].  After  a  median  follow-up  period  of  8.4
onths,  the  percentage  of  pacing  was  signiﬁcantly  higher
n  the  DDD  group  and,  moreover,  there  were  more  events
n  relation  to  the  combined  endpoint  of  death  and  heart
ailure  in  this  group  (HR  1.6;  P  =  0.03).  These  data  imply
ot  only  the  role  of  RVAP  but  also  that  of  elevated  heart
ate  in  the  occurrence  of  cardiovascular  events  [16]. How-
ver,  the  percentage  of  RVAP  cases  exhibiting  deleterious
ffects  has  not  been  clearly  established  and  the  popula-
ions  most  at  risk  of  developing  such  effects  have  not  been
dentiﬁed,  although  there  appears  to  be  a  trend  pointing
owards  patients  with  underlying  conduction  problems  or
oronaropathy  [24].  Nonetheless,  in  daily  practice,  not  all
atients  beneﬁting  from  RVAP  will  develop  LV  dysfunction.
he  risk  was  estimated  at  9%  in  a  retrospective  study  on  286
atients  beneﬁting  from  atrioventricular  node  ablation  [25]
nd  at  26%  in  another  retrospective  study  on  304  patients
ndergoing  deﬁnitive  cardiac  pacing  for  high-degree  atrio-
entricular  block  after  a  follow-up  period  of  6.5  years  [26].
hese  ﬁgures,  however,  differ  from  the  percentage  of  ventri-
ular  asynchronism  reported  in  numerous  studies,  estimated
t  50%  in  the  acute  phase  [24].  The  potential  deleterious
ffect  of  RVAP  is  also  shown  by  interpreting  the  beneﬁt  of
RT  in  patients  with  LV  dysfunction  and  cardiac  pacemaker
24].  All  of  the  studies  demonstrating  the  beneﬁts  of  CRT
n  patients  with  heart  failure  and  RVAP  were  reported  in  a
iterature  review  by  Tops  et  al.  [24].
However,  all  these  studies  concern  the  deleterious  effect
f  long-term  ventricular  pacing  rather  than  the  conse-
uences  of  right  apical  pacing.  The  studies  presented  point
ut  that  one  should  not  pace  the  ventricle  if  it  is  not  neces-
ary  but  there  is  no  clinical  evidence  yet  that  these  studies
i
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ill  be  different  with  septal  pacing.  To  our  knowledge,  no
linical  studies  have  been  published  so  far  demonstrating  a
ore  deleterious  clinical  long-term  effect  of  RVAP  compared
ith  septal  pacing.
hat are the different pacing modes
vailable as alternatives to RVAP?
he  alternatives  to  RVAP  are  numerous  but  not  well  deﬁned
27—33]:  they  include  His-bundle  pacing  and  para-His  pac-
ng,  medial  septum,  lower  septum,  RVOT  in  the  septal  region
nd,  ﬁnally,  pulmonary  infundibulum  [28,30]. The  most  stud-
ed  area  of  pacing  is  RVOT  in  the  septal  region  (septal
VOT),  given  the  ease  of  catheter  implantation  and  catheter
tability  in  this  region,  as  well  as  reproducibility  of  the
ethod  [27—33]. To  better  comprehend  the  areas  to  stim-
late  at  the  location  termed  RVOT,  a  full  understanding  of
natomy  is  necessary  [28]. This  area  was  fully  described  in
he  recent  work  of  Hillock  and  Mond  [28]. The  area  of  the
VOT  includes  several  parts,  with  the  septum  behind,  RV
ree  wall  in  front  and  a part  of  the  anterior  wall  (Fig.  1);
his  area  is  surrounded  by  the  pulmonary  valve  above  and
he  tricuspid  valve  below.  Of  most  interest  to  us  is  the
eptal  area:  being  situated  in  the  lower  part  of  this  area
s  more  favourable  to  physiological  pacing,  which  would
ot  be  the  case  if  pacing  were  done  in  the  upper  part  of
he  infundibulum,  which  is  closer  to  the  aorta  than  the  LV.
he  infundibular  region  (conus  arteriosus)  is  too  high  and
hin  to  be  an  area  suitable  for  pacing.  In  addition,  pacing
hresholds  are  generally  increased  in  this  region  [28].  Con-
equently,  only  the  low  septal  RVOT  may  be  considered  a
uitable  area  for  pacing;  it  is  situated  just  below  the  region
nown  as  ‘crista  supraventricularis’  and  contains  trabecu-
ations,  which  facilitate  the  implantation  of  a  stimulation
atheter  [28]  (Fig.  1).
In  practice,  the  region  being  stimulated  requires  three
adioscopic  views  (Figs.  2—4):  the  anteroposterior  view  in
rder  to  put  the  catheter  between  the  RVOT  and  the  middle
art  of  the  septum;  the  left  anterior  oblique  view  to  differ-
ntiate  the  septal  region  from  the  RV  free  wall,  the  septal
osition  being  characterized  by  the  posterior  orientation  of
he  catheter  in  a  column  direction  in  this  instance;  and  the
ight  anterior  oblique  view,  serving  to  avoid  positioning  of
he  catheter  at  the  level  of  the  coronary  sinus  ostium.
In  terms  of  electrocardiography,  the  correct  positioning
f  the  pacing  catheter  at  the  septal  level  is  characterized
y  a  narrower  QRS  wave  compared  with  other  RV  areas
nd,  particularly,  by  a  negative  or  isoelectric  vector  in  D1,
hereas  it  would  be  positive  if  the  catheter  were  positioned
t  the  RV  level.  In  precordial  derivations,  if  the  septal  posi-
ioning  is  correct,  broad  R  waves  are  recorded  from  V3  to
6,  whereas  if  the  pacing  occurs  at  the  RV  level,  the  R  waves
re  negative  in  V5  to  V6  [28].  The  implantation  technique
as  previously  described,  using  stylet  with  posterior  angu-
ation  [34]. The  feasibility  of  this  technique  was  very  good,
orresponding  to  97%  of  catheters  implanted  in  this  septal
nfundibular  region.  Failures  occurred  in  the  subgroups  of
atients  exhibiting  AF,  considerable  dilatation  of  the  right
avities  or  high-grade  tricuspid  insufﬁciency  [34].  The  risk
f  displacement  was  the  same  as  with  RVAP.
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What about scientiﬁc evidence in favour
of systematic septal pacing?
RVAP  was  initially  chosen  on  account  of  its  simplicity  and
low  displacement  rate,  with  low  pacing  thresholds.  At  the
start  of  the  1980s,  the  use  of  screw  catheters  and  other
pacing  sites,  such  as  RVOT  or  interventricular  septum,  were
tested  in  order  to  reduce  the  risks  of  asynchronous  pacing.
Few  studies  have  evaluated  the  beneﬁt  of  a  more  physio-
logical  septal  RVOT  pacing,  with  patient  numbers  that  were
too  low  to  show  the  superiority  of  this  technique  compared
with  RV  pacing.  These  studies  were  combined  in  2003  by
de  Cock  et  al.  in  the  form  of  a  meta-analysis  (Fig.  5) [35].
In  this  meta-analysis,  only  two  studies  demonstrated  long-
term  beneﬁts  of  RVOT  pacing,  while  the  others  revealed
haemodynamic  beneﬁt  only  in  the  acute  phase  [36,37].  The
studies  varied  widely  in  terms  of  statistical  strength,  with
populations  ranging  from  11  to  92  patients  [38].  Exclud-
ing  the  study  of  Giudici  et  al.,  comprising  92  patients,  the
effect  demonstrated  in  the  meta-analysis  was  at  the  limit  of
signiﬁcance  [38].
The  subgroups  beneﬁting  the  most  from  septal  RVOT  pac-
ing  were  patients  with  a  lower  cardiac  output,  patients  for
whom  QRS  narrowed  with  pacing  and  even  patients  with
a  low  EF  and  associated  coronary  heart  disease  [39,40].
Although  septal  RVOT  pacing  is  as  reliable  as  RV  pacing,
numerous  limitations  were  discussed  in  this  meta-analysis,
which  do  not  allow  the  advantages  of  septal  pacing  to  be
categorically  determined:  the  lack  of  standardization  of  the
pacing  site,  as  only  60%  of  catheters  were  actually  placed
in  the  infundibular  septum  in  these  studies;  considerable
variability  in  the  evaluation  criteria  of  the  studies,  with
measurements  based  on  isotopic  EF,  ultrasound,  dP/dt  or
cardiac  output;  low  patient  numbers  in  each  study;  inclusion
of  both  prospective  and  retrospective  studies;  largely  insuf-
ﬁcient  follow-up;  monocentric  studies  [15]. More  recently,
Bourke  et  al.  compared  RVAP  and  RVOT  septal  pacing  in  20
patients  beneﬁting  from  atrioventricular  node  ablation  for
AF,  with  the  results  showing  that  EF  was  better  preserved
t
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a
Ctal anatomy [28]. Reprinted with permission of Europace.
t  23  weeks  when  using  RVOT  septal  pacing  [41].  A  ran-
omized  study  on  the  two  pacing  modes  was  conducted  in
4  patients  with  complete  atrioventricular  block  requiring
ermanent  pacing,  with  clear  beneﬁt  on  regional  contrac-
ion  and  long-term  (18-month)  EF  shown  in  favour  of  RVOT
eptal  pacing  [41]. These  data  thus  favour  the  long-term
eneﬁt  of  RVOT  septal  pacing  compared  with  RVAP  [41,42].
owever,  debate  still  continues,  notably  with  the  work  of
aye  et  al.  on  103  patients,  which  did  not  reveal  any  dif-
erence  between  the  two  techniques  in  terms  of  improved
uality  of  life  in  patients  with  heart  failure  and  AF  selected
n  the  basis  of  LVEF  less  or  equal  to  40%  [29].  The  deci-
ive  point  in  these  studies  concerns  the  follow-up  period.
tudies  with  a  follow-up  of  several  months  were  generally
egative,  while  those  with  a  follow-up  period  of  more  than
2  months  showed  positive  effects.  It  is  therefore  clear  that
he  negative  remodelling  of  RVAP  occurs  over  several  months
Table  1).
A recently  published  meta-analysis  by  Shimony  et  al.
ncluded  all  of  the  randomized  studies  comparing  RVAP  and
on-apical  pacing  (His,  para-His  and  mid-septal  pacing)  [43].
 total  of  754  patients  from  14  studies  were  analysed,  with
85  undergoing  ‘septal’  pacing  and  369  RVAP.  A  favourable
ffect  on  EF  was  demonstrated  for  follow-up  periods  more
han  12  months  and  for  patients  with  EF  less  or  equal  to
5%.  In  contrast,  no  signiﬁcant  difference  was  found  in  terms
f  quality  of  life,  functional  tests  (walking  test,  maximum
xygen  consumption)  and  morbimortality  rates  (Fig.  6)  [43].
ole of RV lead position in patients in CRT
opulation
he  beneﬁt  of  lateral  and  basal  LV  lead  position  was  truly
emonstrated  in  patients  who  were  given  a  CRT  device;  on
he  other  hand,  only  a  few  studies  have  studied  the  role  of
V  lead  position  [44—46].  The  positioning  of  the  RV  catheter
t  the  apex  or  across  the  septum  in  patients  undergoing
RT  did  not  appear  to  exhibit  different  haemodynamic  and
398  A.  Da  Costa  et  al.
Figure 2. Posteroanterior (PA), 40◦ right anterior oblique (RAO), left lateral (LL) and 40◦ left anterior oblique (LAO) ﬂuoroscopic chest
images of a dual-chamber pacing system to demonstrate a lead catheter attached to the right ventricular outﬂow tract septum [28].
Reprinted with permission of Europace.
Table  1  Summary  of  studies  comparing  right  ventricular  apical  pacing  and  other  sites  of  right  ventricular  pacing.
Study  Patients  (n)  Pacing  site  Evaluation  criteria  Follow-up  (months)  Results
Victor  et  al.,  1999  [37]  16  RVOT  NYHA;  VO2 max;  isotopic  EF  3  (−)
Mera  et  al.,  1999  [36]  12  Septal  RVOT  Isotopic  EF  2  (+)
Stambler  et  al.,  2003  [32]  80  RVOT  EF;  quality  of  life;  walking  test  3  (−)
Bourke  et  al.,  2002  [41]  20  RVOT  Isotopic  EF  4  (−)
Victor  et  al.,  2006  [55]  28  Septal  RVOT  Isotopic  EF  3  (−)
Muto  et  al.,  2007  [56]  233  Mid-RV  septum  Ultrasound  EF  18  (+)
Tse  et  al.,  2002  [42]  24  RVOT  Isotopic  EF  18  (+)
Vanerio  et  al.,  2008  [57]  150  RVOT  Mortality  18  (−)
Kypta  et  al.,  2008  [58]  12  Septal  RVOT  Ultrasound  EF  18  (+)
Tse  et  al.,  2009  [59]  12  Septal  RVOT  Isotopic  EF;  walking  test  18  (+)
Flevari  et  al.,  2009  [27] 31  Mid-septum  Ultrasound  EF  12  (+)
EF: ejection fraction; NYHA: New York Heart Association; RV: right ventricle; RVOT: right ventricular outﬂow tract; VO2: oxygen
consumption.
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Figure 3. Forty degree left anterior oblique ﬂuoroscopic chest images to demonstrate lead positions in the right ventricle [28]. Reprinted
with permission of Europace.
anter
esy.Figure 4. Right anterior oblique (RAO) (40◦) and left lateral (LL) 
From [55], with the authorization of Prof. J. C. Daubert, with courtclinical  effects,  as  demonstrated  recently  in  a  prospective
crossover  study  [47].  To  date,  the  studies  studying  the  role
of  septal  position  were  either  retrospective  or  too  [OK]  low
powered  to  demonstrate  any  signiﬁcant  effect  [44,45,47].
T
r
(
i
Table  2  Summary  of  studies  comparing  right  ventricular  apic
in  patient  populations  requiring  cardiac  resynchronization  ther
Study  Patients  (n)  Follow-up  (m
Thébault  et  al.,  2012  [46] 346  12.6  
Rönn  et  al.,  2011  [47] 33  AF 6 
Kristiansen  et  al.,  2012  [45] 85  6  
Khan  et  al.,  2011  [44]  131  6  
All  four  studies  595  8  
AF: atrial ﬁbrillation; NS: not signiﬁcant.oposterior oblique views.hese  results  have  been  conﬁrmed  and  emphasized  in  three
andomized  studies,  including  a  REVERSE  substudy  [44—46]
Table  2).  The  largest  study  evaluating  the  RV  lead  position
n  patients  requiring  a  CRT  was  the  REVERSE  trial  substudy
al  pacing  and  right  ventricular  outﬂow  tract  septal  pacing
apy.
onths)  Effect  Criteria
NS  Heart  failure;  mortality;  echo  data
NS  Heart  failure;  echo  data
NS  Heart  failure;  echo  data
NS  Heart  failure;  echo  data
NS  Heart  failure;  echo  data
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Figure 5. Meta-analysis of de Cock et al. [35].
Figure 6. Forest plot comparing the effect of right ventricular apical pacing versus non-apical pacing on left ventricular ejection fraction
(
m
LVEF) at the end of follow-up in randomized-controlled trials with mid
ean difference.- and long-term follow-up [43]. ID: identiﬁcation; WMD: weighted
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published  by  Thébault  et  al.  [46].  The  position  of  the  RV  lead
tip  was  apical  in  68.7%  and  non-apical  in  31.3%  of  patients
(n  =  346),  including  the  high  septum  in  4.3%,  mid-septum
in  24%  and  free  wall  in  2.9%.  The  percentage  of  worsened
patients  (study  primary  endpoint)  was  not  different  in  this
subset  of  patients  with  non-apical  RV  positioning  and  in
patients  with  RVAP  and  the  echo  response  variables  were
also  similar  (P  =  0.16)  [46].  Consequently,  the  retrospective
and  prospective  studies  published  so  far  do  not  support  the
use  of  alternate  RV  stimulation  sites  for  CRT,  although  this
remains  to  be  deﬁnitively  demonstrated  in  a  randomized
prospective  study.
Septal pacing and deﬁbrillation leads
Concerning  deﬁbrillation  catheters,  given  their  greater
rigidity,  it  was  supposed  that  the  risk  of  perforation  would
be  less  elevated  if  infundibular  septal  pacing  was  conducted
without  affecting  the  pacing  and  deﬁbrillation  thresholds,  as
already  discussed  [28,48—50].  The  only  randomized  study
designed  to  evaluate  the  feasibility  and  performance  of
RV  mid-septal  versus  apical  implantable  deﬁbrillator  lead
placement  was  recently  published  by  Mabo  et  al.  [50].
The  authors  demonstrated,  in  a  quite  well  designed  study
that  included  215  patients,  the  non-inferiority  of  the  per-
formance  of  implantable  cardioverter-deﬁbrillator  leads
implanted  in  the  right  mid-septum  versus  the  apex  position.
Septal  lead  positioning  was  obtained  89.7%  vs.  91.7%  in  the
other  group  (not  signiﬁcant)  and  the  1-year  rates  of  related
adverse  events  were  similar  in  both  groups  as  were  the  per-
centages  of  inappropriate  therapies  (7.9%  vs.  7.8%)  [50]. All
cause  mortality  was  7.9%  in  the  RV  mid-septal  group  and
2.9%  in  the  RV  apical  group;  the  difference  was  signiﬁcant  in
the  subset  of  patients  with  LVEF  less  or  equal  to  30%.  Accord-
ingly,  no  deﬁnitive  conclusions  can  be  made  regarding  major
adverse  events  or  haemodynamic  effects  of  septal  versus
apical  pacing  essentially  due  to  the  low  pacing  rate  in  both
groups  [50].
His-bundle pacing
Another  type  of  pacing  has  been  the  subject  of  several  stud-
ies:  namely,  His-bundle  pacing  that  allows  the  physiological
ventricular  activation  sequence  to  be  preserved  [51—53].
This  technique  was  tested  in  combination  with  auriculoven-
tricular  node  ablation  in  patients  with  auricular  ﬁbrillation
with  heart  failure  and  narrow  QRS  [51—53].  Deshmukh  et  al.
also  demonstrated  that  His-bundle  pacing  was  feasible  in
this  subgroup  of  patients,  with  an  improvement  in  LV  func-
tion  variables  using  ultrasound  [51—53].  However,  a  number
of  limitations  were  found  in  this  study:  the  absence  of  a
control  group;  the  almost  systematic  use  of  auriculoventric-
ular  node  ablation  (83%  of  patients  permanently  implanted);
and  the  feasibility  of  the  technique  (78%),  with  sometimes
long  and  difﬁcult  procedures  [52].  Despite  initially  promis-
ing  results,  the  feasibility  of  this  technique  in  practice
appears  insufﬁcient  compared  with  RVOT  septal  pacing,
despite  using  a  dedicated  catheter  (4.1  French)  developed
by  Medtronic  (Select  Secure;  Medtronic  Inc.,  Minneapolis,
MN,  USA)  and  requiring  a  catheter  guide  [28,34].  A  recent401
ublished  study  demonstrated  that  the  feasibility  of  His-
undle  pacing  in  a  large  population  of  133  patients  was  low
close  to  44%)  [54].
onclusion
VOT  septal  pacing  has  not  yet  been  proven  to  provide
eneﬁts  in  randomized  studies  but  indirect  data  favour  its
se  compared  with  apical  pacing.  Several  randomized  stud-
es  are  currently  ongoing,  based  on  an  exact  deﬁnition
f  the  position  of  septal  pacing  by  means  of  radioscopy,
sing  catheters  and  guides  for  proper  positioning.  Three
rospective  randomized  multicentre  studies  were  initiated,
lthough  one  was  stopped  due  to  difﬁculties  in  positioning
he  catheters  in  the  ventricular  septum  (Optimize  RV  Selec-
ive  Site  Pacing  Clinical  Trial).  The  two  other  studies  are  still
ngoing,  namely  the  Protect  Pace  and  RASP  trials,  which  are
imed  at  evaluating  RVOT  septal  pacing  compared  with  RVAP
29].
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